Small-molecule focal adhesion kinase (FAK) inhibitors
US12365696B2 · kind B2 · utility
0Cited by
1References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 7, 2020 |
| Grant date | Jul 22, 2025 |
| Priority date | — |
| Expiry date | Oct 31, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compounds that possess inhibitory activity against FAK. Also disclosed are pharmaceutical compositions containing the compounds and methods of using the compounds to treat cancer mediated by aberrant FAK activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.